Neurobiologic Function and Temperament in Subjects with Personality Disorders

CNS Spectrums

Volumn 8, Issue 10, 2003, Pages 725-730

  Mitropoulou, Vivian ^a   Trestman, Robert L ^c   New, Antonia S ^a   Flory, Janine D ^b   Silverman, Jeremy M ^a   Siever, Larry J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; CLONIDINE; DOPAMINE; GROWTH HORMONE; HOMOVANILLIC ACID; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; COHORT ANALYSIS; CORRELATION ANALYSIS; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOAMINE METABOLISM; NEUROBIOLOGY; NEUROTRANSMITTER RELEASE; NORADRENERGIC SYSTEM; PERSONALITY DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; SCORING SYSTEM; SEROTONIN RELEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TEMPERAMENT; TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE; BLOOD; BRAIN; CEREBROSPINAL FLUID; CIRCADIAN RHYTHM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE; FEMALE; HOMOVANILLIC ACID; HUMANS; MALE; PERSONALITY DISORDERS; SEROTONIN; SEVERITY OF ILLNESS INDEX; TEMPERAMENT; TIME FACTORS;

EID: 1542288778     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290001909X     Document Type: Article

References (36)

1. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44:573-588.
2. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975-990.
3. Cloninger CR, Bayon C, Svrakic DM. Measurement of temperament and character in mood disorders: a model of fundamental states as personality types. J Affect Disord. 1998;51:21-32.
4. Tancer ME, Ranc J, Golden RN. Pharmacological challenge test of the Tridimensional Personality Questionnaire in patients with social phobia and normal volunteers. Anxiety. 1994-95;1:224-226.
5. Waller DA, Gullion CM, Petty F, Hardy BW, Murdock MV, Rush AJ. Tridimensional Personality Questionnaire and serotonin in bulimia nervosa. Psychiatry Res. 1993;48:9-15.
6. Wiesbeck GA, Mauerer C, Thome J, Jakob F, Boening J. Neuroendocrine support for a relationship between "novelty seeking" and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology. 1995;20:755-761.
7. Evans J, Platts H, Lightman S, Nutt D. Impulsiveness and the prolactin response to d-fenfluramine. Psychopharmacology (Berl). 2000;149:147-152.
8. Nelson EC, Cloninger CR, Przybeck TR, Csernansky JG. Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sample. Biol Psychiatry. 1996;15;40:271-278.
9. Pfohl B, Black D, Noyes R Jr, Kelley M, Blum N. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder. Biol Psychiatry. 1990;28:41-46.
10. Hansenne M, Ansseau M. Harm avoidance and serotonin. Biol Psychol. 1999;51:77-81
11. Hennig J, Toll C, Schonlau P, Rohrmann S, Netter P. Endocrine responses after d-denfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality. Neuropsychobiology. 2000;41:38-47.
12. Benjamin J, Osher Y, Kotler M, et al. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol-O-methyltransferase (COMT). Mol Psychiatry. 2000;5:96-100.
13. Malhotra AK, Virkkunen M, Rooney W, Eggert M, Linnoila M, Goldman D. The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry. 1996;1:388-391.
14. Mulder RT, Joyce PR. Relationship of temperament and behaviour measures to the prolactin response to fenfluramine in depressed men. Psychiatry Res. 2002;109:221-228.
15. Ruegg RG, Gilmore J, Ekstrom RD, et al. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biol Psychiatry. 1997;42:1123-1129.
16. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 2000;25:479-496.
17. Limson R, Goldman D, Roy A, et al. Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Arch Gen Psychiatry. 1991;48:437-441.
18. Diagnostic and Statistical Manual of Mental Disorder. 3rd ed rev. Washington, DC: American Psychiatric Association; 1987.
19. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS). New York, NY: New York State Psychiatric Institute, Biometrics Research; 1978.
20. Pfohl B, Stangl D, Zimmerman M. Semi-structured interview for DSM-III-R Persortality Disorder. Iowa City, IA: University of Iowa Press; 1989.
21. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989;46:587-599.
22. Trestman RL, Coccaro EF, Mitropoulou V, Gabriel SM, Horvath T, Siever LJ. The cortisol response to clonidine in acute and remitted depressed men. Biol Psychiatry. 1993;15;34:373-379.
23. Siever LJ, Amin F, Coccaro EF, et al. CSF homovanillic acid in schizotypal personality disorder. Am J Psychiatry. 1993;150:149-151.
24. Amin F, Davidson M, Davis KL. Homovanillic acid measurement in clinical research: a review of methodology. Schizophr Bull. 1992;18:123-148.
25. Scheinin M, Chang WH, Jimerson DC, Linnoila M. Measurement of 3-methoxy-4-hydroxyphenylglycol in human plasma with high-performance liquid chromatography using electrochemical detection. Anal Biochem. 1983;132:165-170.
26. Cloninger CR, Przybeck TR, Svrakic DM. The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep. 1991;69(3 pt 1):1047-1057.
27. Eysenck HJ. The Biological Basis of Personality. Springfield, Ill: Charles C. Thomas; 1967.
28. Siever LJ, Davis KL. A psychobiological perspective on the personality disorders. Am J Psychiatry. 1991;148:1647-658.
29. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry. 1987;44:241-247.
30. Roy A, Agren H, Pickar D, et al. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry. 1986;143:1539-1545.
31. New AS, Trestman RL, Mitropoulou V, et al. Serotonergic function and self-injurious behavior in personality disorder patients. J Psychiatry Res. 1997;69:17-26.
32. Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF. Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology. 1998;19:287-299.
33. Goldman RG, Skodol AE, McGrath PJ, Oldham JM. Relationship between the Tridimensional Personality Questionnaire and DSM-III-R personality traits. Am J Psychiatry. 1994;151:274-276.
34. Svrakic DM, Whitehead C, Przybeck TR, Cloninger CR. Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch Gen Psychiatry. 1993;50:991-999.
35. Maggini C, Ampollini P, Marchesi C, Gariboldi S, Cloninger CR. Relationships between Tridimensional Personality Questionnaire Dimensions and DSM-III-R personality traits in Italian adolescents. Compr Psychiatry. 2000;41:426-431.
36. Agren H, Mefford IN, Rudorfer MV, Linnoila M, Potter WZ. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res. 1986;20:175-193.